Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Wow 😯 4c 😮

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Sep 29, 2022 4:49pm

295 Views

Post# 34995975

Wow 😯 4c 😮

From 7c to 4c in less than three weeks. Less than 20M MC. What a Reduvo din worth 50M or 100M. I think they should simply sell it to a big pharma once obtained plus some % on revenue. No point of marketing at this sp. jmo

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China